The evolution of Cerba Research
From a single laboratory to a global research organization, our journey has been defined by scientific excellence, strategic partnerships, and continuous expansion.
1967–2001
Foundations & Early Expansion
Building our scientific expertise and international footprint.
This period laid the foundations of our global network and scientific capabilities.
2007–2017
Integration & Strategic Alignment
Creating a unified platform for global growth.
This phase marked the integration of key capabilities and our transition into a broader international healthcare group.
2018–2019
Acceleration Through Partnerships & Acquisitions
Expanding our global reach and specialized expertise.
This period of rapid expansion strengthened our presence across key regions and advanced scientific domains.
2020
Transformation into Cerba Research
Organizational unification milestone.
This milestone marked the creation of a single, integrated organization dedicated to advancing clinical research worldwide.
2021–2022
Scaling & Global Strengthening
Enhancing our capabilities and global infrastructure.
This period was defined by scaling our operational capacity and strengthening our global network.
2023–Present
Advanced Capabilities & Future Growth
Innovation and next-phase expansion.
We continue to expand our capabilities and invest in next-generation solutions to support the evolving needs of clinical research.
1967
Cerba Lab is founded (medical biology specialization)

1983
BARC Europe (Bio Analytical Research Corporation) is established in Belgium

1996
BARC South Africa (BARC SA) established in Johannesburg

1997
BARC SA and Lancet Laboratories launch joint venture

2001
BARC US founded in New York or BARC establishes its US presence in New York

2007
BARC acquired by Cerba Lab

2009
SRL Medisearch in Japan establishes long-term partnership with Cerba Lab

2015
Cerba Lab becomes Cerba HealthCare, strengthening our global platform

2018
Cerba HealthCare in Europe and Lancet Laboratories in Africa establish joint venture

2018
Teddy Lab in China establishes long-term partnership with Cerba HealthCare

2018
Histalim, a specialty laboratory in France, is acquired by Cerba HealthCare

2019
OWL Metabolomics in Spain partners with Cerba HealthCare

2019
PPC Laboratories in Taiwan establishes long-term partnership with Cerba HealthCare

2020
This milestone marked the creation of a single, integrated organization dedicated to advancing clinical research worldwide.
2021
Cerba Research expands with new facility and extended services in the United States

2021
CerbACT Asia is established as a joint venture between Cerba Research and ACT Genomics in Taiwan

2022
Viroclinics-DDL enters into an acquisition agreement with Cerba Research

2023

2026
Ozette establishes a strategic partnership with Cerba Research

